Skip to main content
. 2019 Jun 25;10(4):1453–1463. doi: 10.1007/s13300-019-0658-7

Table 4.

Adverse events

Adverse events 1 months (n = 102) 3 months
(n = 221)
6 months
(n = 234)
Total n (%) 42 (41.2) 42 (19.0) 25 (10.7)
Nausea 27 (26.4) 14 (6.3) 7 (2.9)
Vomiting 0 (0) 2 (0.9) 0 (0)
Abdominal distension/pain 4 (3.9) 3 (1.3) 2 (0.8)
Dyspepsia 1 (0.9) 3 (1.3) 2 (0.8)
Diarrhea 6 (5.8) 8 (3.6) 4 (1.7)
Constipation 3 (2.9) 3 (1.3) 0 (0)
Injection site reaction 1 (0.9) 3 (1.3) 6 (2.5)
Allergic reaction 1 (0.9) 2 (0.9) 2 (0.8)
Hypoglycemia 0 (0) 3 (1.3) 1 (0.4)
Others 2 (1.9) 4 (1.8) 2 (0.8)

Data are n (%)